|
|
|
Insider
Information: |
Shafer Bradford J |
Relationship: |
EVP, Gen. Counsel, Sec... |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
720,844 |
|
Indirect Shares
|
8,250 |
|
|
Direct
Value |
$9,834,001 |
|
|
Indirect Value
|
$133,568 |
|
|
Total
Shares |
729,094 |
|
|
Total
Value |
$9,967,569 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Innoviva Inc |
INVA |
Sr VP, Gen. Counsel, S... |
2014-08-20 |
443,013 |
2014-08-12 |
8,250 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
EVP, Gen. Counsel, Sec... |
2021-08-20 |
277,831 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
103 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2017-08-20 |
4 |
D |
$27.40 |
$193,965 |
D/D |
(7,079) |
148,997 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2017-09-06 |
4 |
S |
$30.77 |
$451,350 |
D/D |
(14,670) |
134,327 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2017-11-20 |
4 |
D |
$28.58 |
$202,318 |
D/D |
(7,079) |
127,248 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
136,248 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-02-20 |
4 |
D |
$29.09 |
$162,526 |
D/D |
(5,587) |
130,661 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
165,276 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-05-20 |
4 |
D |
$24.31 |
$530,250 |
D/D |
(21,812) |
143,464 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-06-06 |
4 |
S |
$24.09 |
$244,268 |
D/D |
(10,140) |
133,324 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-06-08 |
4 |
S |
$23.66 |
$92,260 |
D/D |
(3,900) |
129,424 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-08-07 |
4 |
S |
$28.03 |
$168,393 |
D/D |
(5,945) |
123,479 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-08-08 |
4 |
S |
$27.85 |
$706,182 |
D/D |
(25,355) |
98,124 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-08-20 |
4 |
D |
$26.95 |
$188,785 |
D/D |
(7,005) |
91,119 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-08-27 |
4 |
S |
$27.71 |
$197,282 |
D/D |
(7,119) |
84,000 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2018-11-20 |
4 |
D |
$24.79 |
$173,679 |
D/D |
(7,006) |
76,994 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
112,250 |
189,244 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2019-02-20 |
4 |
D |
$27.00 |
$156,546 |
D/D |
(5,798) |
183,446 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2019-05-20 |
4 |
D |
$19.84 |
$49,362 |
D/D |
(2,488) |
181,985 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2019-08-20 |
4 |
D |
$21.51 |
$66,337 |
D/D |
(3,084) |
178,901 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2019-11-20 |
4 |
D |
$17.60 |
$62,779 |
D/D |
(3,567) |
175,334 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
119,000 |
294,334 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2020-02-20 |
4 |
D |
$25.90 |
$761,512 |
D/D |
(29,402) |
264,932 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2020-05-20 |
4 |
D |
$26.67 |
$128,203 |
D/D |
(4,807) |
261,527 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2020-08-20 |
4 |
D |
$18.22 |
$87,529 |
D/D |
(4,804) |
256,723 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2020-11-20 |
4 |
D |
$17.21 |
$82,728 |
D/D |
(4,807) |
251,916 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
|
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
316,916 |
0 |
- |
|
103 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|